Investors of Corcept Therapeutics Encouraged to Lead Class Action Lawsuit Against Alleged Securities Fraud Corcept Therapeutics investors are reminded of the opportunity to lead a class action lawsuit due to alleged securities fraud, with a deadline approaching soon.

Investors of Corcept Therapeutics Encouraged to Lead Class Action Lawsuit Against Alleged Securities Fraud #USA #New_York #Rosen_Law_Firm #Corcept_Therapeutics #CORT_stock